Gene Synthesis Technology and Global Markets Report 2023-2028: Technological Innovations and Implications for Healthcare, Research, and Beyond
14 mai 2024 09h27 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Gene Synthesis: Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.The gene synthesis industry, a...
Global Gene Synthesis Market Report 2023-2028: Unveils Emerging Trends and Regional Growth Insights
29 janv. 2024 07h26 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Enzymatic DNA Synthesis Market Analysis, Trends and Forecasts to 2028 - Opportunities in CRISPR-Cas9 Integration and Cell-Free Synthetic Biology
12 déc. 2023 05h23 HE
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Global Enzymatic DNA Synthesis Market: Analysis By Product Type (DNA Library Synthesis and Custom DNA Synthesis), By Technology (PCR, CRISPR, SOLA and...
Enzymatic DNA Synthesis Global Market Report 2023: Growing Demand for Personalized Medicine and DNA Data Storage Drives Sector
02 mai 2023 06h28 HE
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Enzymatic DNA Synthesis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, End User, and Technology" report has...
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
28 févr. 2023 08h28 HE
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
19 oct. 2022 09h00 HE
|
Telesis Bio
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company,...
The DNA synthesis services market is anticipated to grow at an annualized rate of more than 15% by 2035, claims Roots Analysis
30 août 2022 13h05 HE
|
Roots Analysis
London, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “DNA Synthesis Technologies and Services Market, 2022-2035” report to its list of offerings. With an...
Codex DNA Demonstrates End-to-End Workflow for Storing and Retrieving Data in Synthetic DNA
26 avr. 2022 08h03 HE
|
Codex DNA, Inc.
SAN DIEGO, April 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the completion of proof-of-concept...
Codex DNA to Showcase Innovative SOLA Enzymatic DNA Synthesis Technology and Automated Benchtop BioXp System at SynBioBeta’s Built with Biology Global Conference
06 avr. 2022 08h03 HE
|
Codex DNA, Inc.
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker lineup for presentations at...
Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
03 mars 2022 08h03 HE
|
Codex DNA, Inc.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D...